Stay updated on RESILIENT Clinical Trial
Sign up to get notified when there's something new on the RESILIENT Clinical Trial page.

Latest updates to the RESILIENT Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe ClinicalTrials.gov record for the completed bimagrumab study is displayed, including its study design, eligibility criteria, locations, and outcome measures.SummaryDifference67%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the study record page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA sitewide banner announces updates to NIH terminology, including the transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check60 days agoChange DetectedAccess to the study record has been restricted; the page now shows a 403 Forbidden error. Previously visible study details and navigation have been removed.SummaryDifference18%

Stay in the know with updates to RESILIENT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RESILIENT Clinical Trial page.